1H and 13C NMR spectra of condensed benzimidazole and imidazobenzodiazepines  by El kihel, A. et al.
Arabian Journal of Chemistry (2012) 5, 523–526King Saud University
Arabian Journal of Chemistry
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLE1H and 13C NMR spectra of condensed benzimidazole
and imidazobenzodiazepinesA. El kihel a,*, E.M. Essassi b, P. Bauchat ca Laboratoire de Chimie Bioorganique, Faculte´ des Sciences, BP20, El Jadida, Maroc 24000, Morocco
b Laboratoire de Chimie Organique He´te´rocyclique, Faculte´ des Sciences, Avenue Ibn Battouta, Rabat, Maroc 10000, Morocco
c Laboratoire de Synthe`se et Electrosynthe`se Organique, Universite´ de Rennes1, Avenue Ge´ne´ral Leclerc, 35042 Rennes, FranceReceived 16 September 2010; accepted 17 September 2010
Available online 23 September 2010*
52
E
18
El
Pe
doKEYWORDS
Benzimidazole;
Imidazobenzodiazepines;
1H and 13C NMR;
1H–13C correlationCorresponding author. T
3342187.
-mail address: elkihelabdella
78-5352 ª 2010 King Saud
sevier B.V. All rights reserve
er-review under responsibilit
i:10.1016/j.arabjc.2010.09.02
Production and hel.: +2
tif1@yah
Universit
d.
y of King
1
osting by EAbstract Benzimidazoles are heterocyclic compounds that have awakened great interest during the
last few years because of their proven biological activity as antiviral, antimicrobial, and antitumoral
agents. For this reason, the development of a systematic NMR study of condensed benzimidazole
compounds constitutes a signiﬁcant tool in understanding the molecular dynamics and the struc-
tural parameters that govern their behavior. The 1H and 13C NMR spectra of new imi-
dazobenzodiazepines were investigated. Based on the study of NMR chemical shifts, we discuss
the environmental effect of the nucleus 13C. The correlation 1H–13C proved to be a useful method
for distinguishing the assignment of carbon.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The benzimidazole nucleus and its derivatives are known to
play extremely crucial roles in the structures and functions of
a number of biologically important molecules, generally by12 523343003; fax: +212
oo.fr (A. El kihel).
y. Production and hosting by
Saud University.
lseviervirtue of their being coordinated to metal ions. The incorpora-
tion of the benzimidazole nuclei is an important synthetic
strategy in drug discovery (Townsend, 1976). The high thera-
peutic properties of the related drugs have encouraged the
medicinal chemists to synthesize the large number of novel
chemotherapeutic agents (Kleeman et al., 1999). Pharmaceuti-
cal properties including: antiviral (Cheng et al., 2005), antitu-
moral (Yang et al., 2009; Charlson et al., 1973), antifungal
and antimycotic (Walker et al., 1978), antihistaminic and
antiallergic (Nakano et al., 2000), antimicrobial (Marquis
et al., 2006), antihelminthic (Mavrova, 2006) and spasmolytic
activity (Navarrete-Va´zquez et al., 2006). These different appli-
cations have attracted many experimentalists and theorists to
investigate the spectroscopic and structural properties of benz-
imidazole (Mohan, 1991; Klots et al., 1997; Morsy et al., 2002)
and some of its derivatives (Yurdakul and Yilmaz, 1999).
In this work, we report the study of NMR spectra of
condensed benzimidazoles. We have previously described
524 A. El kihel et al.the synthesis of 4-(2,5,6-trimethyl-1H-benzo[d]imidazol-7-yla-
mino) pent-3-en-2-one 1a, ethyl 3-(2,5,6-trimethyl-1H-ben-
zo[d] imidazol-7-ylamino)but-2-enoate 1b, 4-acetonylidene-5-
acetyl-2,6, 8,9-tetramethyl-7H-imidazo-[1,5,4-e,f][1,5]-benzo-
diazepine 2a and 4-acetonylidene-5-ethoxycarbonyl-2,6,8,9-
tetramethyl-7H-imidazo-[1,5,4-e,f][1,5]-benzodiazepine 2b (El
kihel et al., 2008). The NMR parameters of these heterocy-
cles are reported in this paper.
2. Results and discussion
A variety of works are reported about the NMR of benz-
imidazole derivatives (Embrey and Craik, 1995; Infante-Cas-
tillo et al., 2008; El kihel et al., 2005) The 13C NMR
spectra and the charge density of carbon for the benzimid-
azole were reported by Pugmire and Grant (1971). The
chemical shifts of carbon 13 for some benzimidazoles
substituted in position 5 were published (Mathias and
Overberger, 1978; Fruchier et al., 1980; Blackburn et al.,
1982; Lopyrev et al., 1981, 1985). Other works have re-
ported the NMR of some bisbenzimidazoles and condensed
benzimidazoles (Dall’Oglio et al., 2002; Alcade et al., 1991;
Goljer et al., 1985). After the study of the behavior of theN
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Figure 2 The numbering of the compo13C NMR spectra in the benzimidazole series (Goljer et al.,
1985), we are interested to report our contribution in this
area by using NMR spectroscopy for the elucidation of
carbon13 chemical shifts of these benzimidazole derivatives.
We have studied the inﬂuence of the substituents on the
13C NMR spectra of these compounds. The complete
assignment of the resonances of the 13C NMR spectra of
the benzimidazole derivatives was carried out by selective
decoupling, NOE, and H, C-COSY experiments (see Figs.
1 and 2).
3. Results and discussion
Tables 1 and 2 give the 1H and 13C NMR data, respectively; of
1a, 1b, 2a and 2b.
The benzimidazole presents a rapid tautomerism which
does not allow to obtain all expected signals in the 13C
NMR spectra in the case of substituted benzimidazoles by het-
erocycles(El Kihel et al., 2005).
This phenomenon was not observed for the open chain
intermediates 1a and 1b or the condensed benzimidazoles 2a
and 2b, the 13C NMR spectra of these compounds present
all the expected signals.N
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Table 1 1H NMR data of the studied compounds.
Proton Compounds
1a 1b 2a 2b
H1 10.19(br s, cyclic NH) 9.99(br s, cyclic NH)
H4 7.21(s) 7.22(s) 7.36(s) 7.43(s)
H10 2.44(s, CH3) 2.45(s, CH3) 2.54(s, CH3) 2.45(s, CH3)
H11 2.31(s, CH3) 2.33(s, CH3) 2.42(s, CH3) 2.37(s, CH3)
H12 2.00(s, CH3) 2.10(s, CH3) 1.95(s, CH3) 1.67(s, CH3)
H14 5.25(s, oleﬁnic H) 4.69(s, oleﬁnic H)
H16 1.87(s, CH3) 1.22(t, CH3), 1.79(s, CH3) 1.24(t, CH3)
4.07(q, CH2) 4.21(q, CH2)
H17 2.13(s, CH3) 2.16(s, CH3) 2.37(s, CH3) 1.95(s, CH3)
H18 12.23(s, NH) 12.32(s, NH) 15.81(s, NH) 12.54(s, NH)
H19 6.20(s, oleﬁnic H) 6.28(s, oleﬁnic H)
H21 1.80(s, CH3) 1.69(s, CH3)
Table 2 13C NMR data of the studied compounds.
Carbon Compounds chemical shifts (ppm)
1a 1b 2a 2b
C2 150.8 159.6 145.2 146.7
C4 110.2 110.2 99.7 112.9
C5 129.8 126.4 132.3 131.1
C6 124.8 117.2 126.8 125.9
C7 130.1 130.1 134.3 133.6
C8 125.6 120.8 128.4 126.1
C9 147.5 150.5 139.1 138.0
C10 14.5 20.6 14.4 14.4
C11 20.5 19.5 18.2 17.1
C12 13.8 14.5 13.3 13.9
C13 162.7 161.6 147.3 149.8
C14 95.8 83.0 124.7 123.5
C15 194.4 169.7 204.1 166.8
C16 38.5 18.3, 57.8 20.1 13.1, 60.7
C17 28.7 48.6 19.2 19.6
C18 154.1 152.6
C19 105.1 116.6
C20 173.3 174.1
C21 20.3 20.3
1H and 13C NMR spectra of condensed benzimidazole and imidazobenzodiazepines 525For the condensed benzimidazoles as imidazobenzodiaze-
pines, we have studied the chemical shifts of vinyl and car-
bonyl group in order to see the effect of conjugated
system.
For the 13C NMR spectra of compounds 2a and 2b, the
conjugated system induces a systematic shielding of the car-
bonyl group in position 20 (d= 173.3 ppm for compound 2a
and d= 174.1 ppm for compound 2b) by comparison of the
chemical shifts of the carbonyl group in position 15
(d= 194.4 ppm for compound 1a and d= 204.1 ppm for
compound 2a) while the same observation applies to the car-
bonyl group of ester with less shielding (d= 169.7 ppm for
compound 1b, d= 166.8 ppm for compound 2b). We also
noted the deshielding of vinyl group CH in compounds 2a
and 2b (d= 105.1 ppm for compound 2a and d= 116.6 ppm
for compound 2b) by comparison of that in compounds 1a
and 1b (d= 95.8 ppm for compound 1a and d= 83.0 ppm
for compound 1b).4. Experimental section
All compounds were characterized by their 1H NMR and 13C
NMR spectra as well as by microanalysis or HRMS spectra.
NMR spectra were recorded on Bruker ARX 200 (200 MHz
for 1H and 50.3 MHz for 13C) spectrometer (O-ppm/TMS,
J-Hz); for 13C NMR, the multiplicities were determined
through DEPT.References
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